UPC_CFI_774/2025

FLUID DELIVERY DEVICE WITH TRANSCUTANEOUS ACCESS TOOL, INSERTION MECHANISM AND BLOOD GLUCOSE MONITORING FOR USE THEREWITH

Prozessuale & UnteranträgeKostenfestsetzungenMilan CDGenericCase Closed

Übersicht Entscheidungen Dokumente Zeitverlauf

Parteien

Kläger

Insulet Corporation

Vertreter: Marc Grunwald; Frank Peterreins

Beklagte

EOFLOW Co., Ltd.

Vertreter: Mirko Weinert; Christopher Pierce

Richter

Andrea Postiglione
Anna-Lena Klein
Uwe Schwengelbeck

Patente

EP4201327

CPC-Codes: A61M5/1723, A61M5/1452, A61M5/158, A61B5/14865, A61M5/14244, F04B9/02, A61B5/14532, A61M2230/201, A61M2005/14506, A61M5/14248, B65D83/761, A61M5/3291…

Sektor: Packaging & Conveying

Ausgang

Nur Kosten

Eingereicht: 21. Aug. 2025

Erste Entscheidung: 15. Okt. 2025

Sprache: English

The Central Division Milan decided a cost application in the Insulet v. EOFLOW proceedings, ruling that costs incurred after publication of the merits decision and enforcement costs fall outside the scope of R. 151 RoP and are not recoverable in the cost decision.

Im UPC-Register öffnen